The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.

However, phase 3 clinical trials for DengiAll, a tetravalent vaccine candidate produced by Panacea Biotec in partnership with ...

Panacea Biotec Inc. being a step-down subsidiary of the company. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its ...

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight ...

Following a UNICEF order worth ₹127 crore, Panacea Biotec shares increased 5% to ₹456.25. The stock has seen substantial ...

Here's What Rules Say Top Stocks To Watch For December 26: BPCL, Panacea Biotec, Apollo Hospitals & Others In Focus Viral ...

In a subdued trading session on Thursday, December 26, the Indian stock markets ended flat, marking a lacklustre close for ...

The Sensex closed unchanged at 78,472, while the Nifty edged 23 points higher to settle at 23,750. This marks the third ...

Sensex erases early gains, hovering around 78,459, while Nifty50 stays above 23,700. Weakness in FMCG and IT stocks weighs on ...

Shares of Panacea Biotec are now locked in an upper circuit of 5% at ₹454.90. With today's surge, the stock has rallied over ...

As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to ...

Panacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its ...